Before you sell to, join or invest in Alessa Therapeutics, Inc.
MentionFox check on Alessa Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/alessa-therapeutics-inc-form-d-25000001
Check Alessa Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Alessa Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Alessa Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-05-01.
Alessa Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 1, 2025. The filing reports $25.38M sold. Its industry group is Other Health Care. It names Cam Gallagher (Executive Officer, Director), Richard Lim (Director), Annie Mitsak (Director) (SEC Form D, May 1, 2025).
Is this your company?
Sell to companies like Alessa Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Alessa Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Alessa Therapeutics, Inc., from the filings we hold.
Other Health Care raises by companies based in California, filed in May 2025, largest first.
Get an email when Alessa Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Alessa Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Alessa Therapeutics, Inc. →Get the full cited report on Alessa Therapeutics, Inc.
What the filing shows about Alessa Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Alessa Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Alessa Therapeutics, Inc.'s address as 930 Brittan Avenue, San Carlos, CA 94070.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Alessa Therapeutics, Inc. See pricing
Alessa Therapeutics, Inc. is a registered filer with the SEC (CIK 1771653) and has filed since 2025-05-01. 1 filing is on record, the latest on 2025-05-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Alessa Therapeutics, Inc.'s Form D of 2025-05-01 names Cam Gallagher, Richard Lim, Annie Mitsak and 4 more as its officers, directors or promoters.
Its new offerings report $25.38M sold across 1 offering, as its own filings state.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Alessa Therapeutics is developing a proprietary drug-delivery platform for sustained and localized release of clinically proven therapies to effectively treat early-stage prostate cancer
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Cam Gallagher is named as Executive Officer and Director on the Form D that Alessa Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 7 people that filing names.
Richard Lim is named as Director on the Form D that Alessa Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 7 people that filing names.
Annie Mitsak is named as Director on the Form D that Alessa Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 7 people that filing names.
Douglas Crawford is named as Director on the Form D that Alessa Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 7 people that filing names.
Pamela Munster is named as Director on the Form D that Alessa Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 7 people that filing names.
Steve Tregay is named as Director on the Form D that Alessa Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 7 people that filing names.
Zachary Collins is named as Executive Officer on the Form D that Alessa Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2025-05-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Alessa Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Alessa Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Alessa Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Alessa Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Alessa Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-04 (alessatherapeutics.com).
Each opens in a new tab, filled in for Alessa Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/alessa-therapeutics-inc-form-d-25000001